Point-of-Care Diagnostics Market

Point-of-Care Diagnostics Market (Platform: Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, and Others; Application and End-user) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Point-of-Care Diagnostics Market Outlook 2028

  • The global market was valued at US$ 34.1 Bn in 2020
  • It is expected to grow at a CAGR of 4.7% from 2021 to 2028, reaching a value of US$ 66 billion by the end of 2028.

Analysts’ Viewpoint on Market Scenario

North America is expected to offer lucrative opportunities to the market players. This is due to rising geriatric population and increasing prevalence of cancer, diabetes, and cardiovascular diseases.

The surge in demand for home healthcare services across the globe is creating potential growth prospects for players in the point-of-care diagnostics market.

Moreover, rise in prevalence of infectious diseases such as HIV/AIDS and malaria is expected to drive the demand for point-of-care diagnostics. Favorable reimbursement policies are responsible for the rapid expansion of the global market during the forecast period.

Innovative Strategies Adopted by Market Players to Gain Competitive Benefits

R&D activities have a large part to play in strengthening the growth structure of the point of care diagnostics market. The players indulge in these activities for adding new technologies to the systems. Furthermore, the activities also assist in increasing the revenues of the players in the market.

Strategic collaborations have a major role in expanding the landscape of the point-of-care diagnostics industry. Mergers, acquisitions, joint ventures, and partnerships are important in boosting the influence of the players in various regional pockets. These collaborations also aid in increasing the production capacities of the players in the market, eventually accelerating the growth prospects.

Request a sample to get extensive insights into the Point-of-Care Diagnostics Market

Increase in Preference for Biosensor Integration to Drive Global Market

A blend of biosensors in point-of-care diagnostics devices help improve patient care via real-time and remote health monitoring. Furthermore, label-based techniques are time consuming and cause many complexities. These factors are accelerating the use of point-of-care diagnostics devices, ultimately contributing to the growth structure of the point-of-care diagnostics market.

Point-of-care diagnostics helps healthcare practitioners to efficiently and accurately attain real-time and high-quality results in a short span. These diagnostics help physicians, clinicians, and other healthcare professionals to make quick decisions related to the line of treatment to be given to a patient.

Lucrative Growth Opportunities for North America Market Players

The North America market is expected to account for the largest share of the global market. This can be attributed to the availability of advanced healthcare infrastructure and technological growth.

The market for point-of-care diagnostics in Asia Pacific is projected to expand at a rapid pace during the forecast period. The region is expected to gain market share due to rising population, government initiatives to provide better health care facilities, growing number of patients affected by various viral diseases. Rise in disposable income of people also contributes to the expansion of the market in Asia Pacific.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Point-of-Care Diagnostics Market

Governments Extend Support to Improve Healthcare Infrastructure

Due to the COVID-19 pandemic, an increase in the strain on the healthcare sector was witnessed due to increased hospitalization and complications among many individuals. These aspects are encouraging many government bodies to improve their healthcare infrastructure. This, in turn, is propelling the growth of the point-of-care diagnostics market.

The advantages associated with point-of-care diagnostics devices are estimated to have a positive impact on the growth trajectory of the market during the forecast period. Manufacturers operating in the global point-of-care diagnostics industry are focusing on innovations in services to boost the global market.

Companies in the global market are accelerating product development and unlocking revenue opportunities to obtain competitive benefits. Market stakeholders are extending their services arms to gain competitive edge in healthcare sector.

Impact of Coronavirus on Global Market

The COVID-19 pandemic has changed the growth equation of many industries and sectors in different ways. The growth projections of the market have also been affected due to the pandemic.

Numerous countries are ramping up COVID-19 testing measures for early detection and death prevention due to the infection. The novel coronavirus, if detected at a later stage, may spread at a rapid rate and also infect the lungs, which can prove to be dangerous, or even fatal in some cases. Hence, government bodies are upgrading COVID-19 testing measures. These factors assure accelerated growth of the point of care diagnostics market.

The benefits attached to the use of point-of-care diagnostics as compared to other techniques are predicted to strengthen the growth prospects of the global market. Other aspects such as precision, accuracy, and enhanced sensitivity assist in increasing the growth rate of the market.

Market Overview

  • According to Transparency Market Research’s latest report on the global point-of-care diagnostics market for the historical period 2017–2019 and forecast period 2021–2028, increase in incidence of diabetes, cancer, and other chronic diseases, and technological advancements in the field of point-of-care that has resulted in new and innovative products are projected to drive the market during the forecast period

Rise in Prevalence of Chronic, Infectious, and Lifestyle Diseases: Key Driver

  • The number of patients inflicted with infectious diseases and other lifestyle diseases is increasing. However, early screening at the onset stage prevents the last stage complications and health care costs for patients.
  • According to the IDF Diabetes Atlas Tenth edition 2021, around 537 million adults (20 years to 79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.
  • Using data from 2015 to 2018, around 93.9 million, or 38.1%, of the U.S. adults had total cholesterol of 200 mg/dL or higher, according to the American Heart Association, Inc.

Technological Innovations to Boost Market Growth

  • Technological innovations that provide early, safe, and accurate results for diagnosis are projected to boost the growth of the global point-of-care diagnostics market. Advanced technology helps in continually updating the market by bringing on better products.
  • Introduction of the fifth generation HIV test for diagnosis helps patients with early detection of HIV infection by diagnosing HIV antigen. The 5th generation HIV test provides more information than ever before about a person's HIV status. Moreover, this test can now detect and identify both HIV-1 and HIV-2 antibodies and the p24 antigen individually in one blood sample, thereby specifically indicating which marker is positive. The 4th generation test reports on all three markers together.
  • In response to the ongoing two-year-long COVID-19 outbreak, the World Health Organization (WHO) has supported bedside diagnostics as a major research priority. In comparison to the gold standard lab-based PCR test, the goal is to enhance turnaround time and ease of use. Rapid antigen tests, alternative DNA amplification technologies, and innovative sensors in close proximity to patients have all been used.
  • With built-in sensors, high-resolution cameras, high-speed wireless connectivity, and the capacity to use numerous applications and apps, smartphones operate as minicomputers for sensitive and particular data quantification. Hence, these can be used in mobile POCT as standalone sensors and detectors.

Lack of Quantification in Results of Point-of-Care Diagnostics to Hamper Global Market

  • Rapid medical diagnostic kits provide for only qualitative results for the tests performed. These results are easily observable. For confirmation of the test results, other diagnostic methods have to be deployed, which increases the health care costs incurred by patients.
  • Rapid diagnostic test kit for malaria was used to check for malarial antigens at onset stage. The results were indicative of the presence of malarial antigens; however, the amount or quantity was not observed.

Competition Landscape

  • This report profiles major players in the global market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global market is consolidated, with the presence of small number of major global players
  • Leading players operating in the global point-of-care diagnostics market are
    • Johnson & Johnson Services, Inc.
    • bioMérieux SA
    • F. Hoffmann-La Roche Ltd.
    • Nova Biomedical
    • Siemens AG
    • Bio Rad Laboratories, Inc.
    • BD
    • Abbott
    • Danaher Corporation
    • Cardinal Health Inc.
    • Thermo Fisher Scientific, Inc., among others

Key Developments

  • Key players in the global point-of-care diagnostics market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global market. A few expansion strategies adopted by players operating in the global point of care diagnostics industry are:
    • In February 2022, Mylab Discovery Solutions announced the approval and launch of CoviSwift for testing for COVID-19. CoviSwift is the first point-of-care testing solution that can be used in small labs, in-hospital labs, and airports. CoviSwift is driven by RT-PCR gold standard technology as against the CoviSelf rapid antigen home testing kit. The test is expected to be available in the market by early February.
    • In April 2021, CA Healthcare Acquisition Corp. announced a definitive merger agreement with LumiraDx Limited. The combination reflects a value of US$ 5.0 Bn for Lumira’s existing equity. Since its formation, LumiraDx has raised US$ 700 Mn in equity capital including investments by Morningside Ventures, U.S. Boston Capital Corporation, the Bill & Melinda Gates Foundation, Petrichor Healthcare Capital Management, and other global strategic partners.
  • The report on the global market discusses individual strategies, followed by company profiles of manufacturers of point-of-care diagnostic devices/kits. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global market.

Point-of-Care Diagnostics Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 34.1 Bn

Market Forecast Value in 2028

US$ 66.0 Bn

Growth Rate (CAGR)

4.7%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market player – Competition matrix (by tier and size of companies)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Platform
    • Lateral Flow Assays
    • Dipsticks
    • Microfluidics
    • Molecular Diagnostics
    • Immunoassays
    • Others
  • Application
    • Glucose Monitoring Products
    • Cardiometabolic Monitoring Products
    • Infectious Disease Testing Products
    • Pregnancy & Fertility Testing Products
    • Urinalysis Testing Products
    • Cholesterol Testing Products
    • Hematology Testing Products
    • Drugs-of-abuse Testing Products
    • Others
  • End-user
    • Hospitals
    • Diagnostic Laboratories
    • Clinics/Physician Offices
    • Home Care
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Johnson & Johnson Services, Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd.
  • Nova Biomedical
  • Siemens AG
  • Bio-Rad Laboratories, Inc.
  • BD
  • Abbott
  • Danaher Corporation
  • Cardinal Health, Inc.
  • Thermo Fisher Scientific, Inc.
  • Other Prominent Players

Customization Scope

Available upon request

Pricing

Available upon request

Point-of-Care Diagnostics Market – Segmentation

Platform
  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays
  • Others
Application
  • Glucose Monitoring Products
  • Cardiometabolic Monitoring Products
  • Infectious Disease Testing Products
  • Pregnancy & Fertility Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Drugs-of-abuse Testing Products
  • Others
End-user
  • Hospitals
  • Diagnostic Laboratories
  • Clinics / Physician Offices
  • Home Care
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of point-of-care diagnostics?

The global market is expected to reach the value of US$ 66 Bn by the end of 2028

What is the anticipated CAGR of the market in the forecast period?

The global market is estimated to expand at a CAGR of 4.7% from 2021 to 2028

What are the key driving factors for the growth of the market?

Point-of-care diagnostics market is driven by rise in prevalence of infectious diseases such as HIV/AIDS and malaria

Which is the rising prominent segment in the market?

The lateral flow assays segment accounted for the largest share of the global point-of-care diagnostics market

Who are the key players in the global point-of-care diagnostics industry?

Key players in the global market include Johnson & Johnson Services, Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd., Nova Biomedical, Siemens AG

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Point-of-Care Diagnostics Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Point-of-Care Diagnostics Market Analysis and Forecast, 2017–2028

            4.4.1. Market Revenue Projections (US$ Mn)

        4.5. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Disease Prevalence & Incidence Rate globally with key countries

        5.2. Technological Advancements

        5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)

        5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    6. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Platform

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Platform, 2017–2028

            6.3.1. Lateral Flow Assays

            6.3.2. Dipsticks

            6.3.3. Microfluidics

            6.3.4. Molecular Diagnostics

            6.3.5. Immunoassays

            6.3.6. Others

        6.4. Market Attractiveness Analysis, by Platform

    7. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Application, 2017–2028

            7.3.1. Glucose Monitoring Products

            7.3.2. Cardiometabolic Monitoring Products

            7.3.3. Infectious Disease Testing Products

            7.3.4. Pregnancy & Fertility Testing Products

            7.3.5. Urinalysis Testing Products

            7.3.6. Cholesterol Testing Products

            7.3.7. Hematology Testing Products

            7.3.8. Drugs-of-abuse Testing Products

            7.3.9. Others

        7.4. Market Attractiveness Analysis, by Application

    8. Global Point-of-Care Diagnostics Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by End-user, 2017–2028

            8.3.1. Hospitals

            8.3.2. Diagnostic Laboratories

            8.3.3. Clinics/Physician Offices

            8.3.4. Home Care

            8.3.5. Others

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Point-of-Care Diagnostics Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Platform, 2017–2028

            10.2.1. Lateral Flow Assays

            10.2.2. Dipsticks

            10.2.3. Microfluidics

            10.2.4. Molecular Diagnostics

            10.2.5. Immunoassays

            10.2.6. Others

        10.3. Market Value Forecast, by Application, 2017–2028

            10.3.1. Glucose Monitoring Products

            10.3.2. Cardiometabolic Monitoring Products

            10.3.3. Infectious Disease Testing Products

            10.3.4. Pregnancy & Fertility Testing Products

            10.3.5. Urinalysis Testing Products

            10.3.6. Cholesterol Testing Products

            10.3.7. Hematology Testing Products

            10.3.8. Drugs-of-abuse Testing Products

            10.3.9. Others

        10.4. Market Value Forecast, by End-user, 2017–2028

            10.4.1. Hospitals

            10.4.2. Diagnostic Laboratories

            10.4.3. Clinics/Physician Offices

            10.4.4. Home Care

            10.4.5. Others

        10.5. Market Value Forecast, by Country, 2017–2028

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Platform

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Point-of-Care Diagnostics Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Platform, 2017–2028

            11.2.1. Lateral Flow Assays

            11.2.2. Dipsticks

            11.2.3. Microfluidics

            11.2.4. Molecular Diagnostics

            11.2.5. Immunoassays

            11.2.6. Others

        11.3. Market Value Forecast, by Application, 2017–2028

            11.3.1. Glucose Monitoring Products

            11.3.2. Cardiometabolic Monitoring Products

            11.3.3. Infectious Disease Testing Products

            11.3.4. Pregnancy & Fertility Testing Products

            11.3.5. Urinalysis Testing Products

            11.3.6. Cholesterol Testing Products

            11.3.7. Hematology Testing Products

            11.3.8. Drugs-of-abuse Testing Products

            11.3.9. Others

        11.4. Market Value Forecast, by End-user, 2017–2028

            11.4.1. Hospitals

            11.4.2. Diagnostic Laboratories

            11.4.3. Clinics/Physician Offices

            11.4.4. Home Care

            11.4.5. Others

        11.5. Market Value Forecast, by Country/Sub-Region, 2017–2028

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Platform

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-Region

    12. Asia Pacific Point-of-Care Diagnostics Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Platform, 2017–2028

            12.2.1. Lateral Flow Assays

            12.2.2. Dipsticks

            12.2.3. Microfluidics

            12.2.4. Molecular Diagnostics

            12.2.5. Immunoassays

            12.2.6. Others

        12.3. Market Value Forecast, by Application, 2017–2028

            12.3.1. Glucose Monitoring Products

            12.3.2. Cardiometabolic Monitoring Products

            12.3.3. Infectious Disease Testing Products

            12.3.4. Pregnancy & Fertility Testing Products

            12.3.5. Urinalysis Testing Products

            12.3.6. Cholesterol Testing Products

            12.3.7. Hematology Testing Products

            12.3.8. Drugs-of-abuse Testing Products

            12.3.9. Others

        12.4. Market Value Forecast, by End-user, 2017–2028

            12.4.1. Hospitals

            12.4.2. Diagnostic Laboratories

            12.4.3. Clinics/Physician Offices

            12.4.4. Home Care

            12.4.5. Others

        12.5. Market Value Forecast, by Country/Sub-Region, 2017–2028

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Platform

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-Region

    13. Latin America Point-of-Care Diagnostics Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Platform, 2017–2028

            13.2.1. Lateral Flow Assays

            13.2.2. Dipsticks

            13.2.3. Microfluidics

            13.2.4. Molecular Diagnostics

            13.2.5. Immunoassays

            13.2.6. Others

        13.3. Market Value Forecast, by Application, 2017–2028

            13.3.1. Glucose Monitoring Products

            13.3.2. Cardiometabolic Monitoring Products

            13.3.3. Infectious Disease Testing Products

            13.3.4. Pregnancy & Fertility Testing Products

            13.3.5. Urinalysis Testing Products

            13.3.6. Cholesterol Testing Products

            13.3.7. Hematology Testing Products

            13.3.8. Drugs-of-abuse Testing Products

            13.3.9. Others

        13.4. Market Value Forecast, by End-user, 2017–2028

            13.4.1. Hospitals

            13.4.2. Diagnostic Laboratories

            13.4.3. Clinics/Physician Offices

            13.4.4. Home Care

            13.4.5. Others

        13.5. Market Value Forecast, by Country/Sub-Region, 2017–2028

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Platform

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-Region

    14. Middle East & Africa Point-of-Care Diagnostics Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Platform, 2017–2028

            14.2.1. Lateral Flow Assays

            14.2.2. Dipsticks

            14.2.3. Microfluidics

            14.2.4. Molecular Diagnostics

            14.2.5. Immunoassays

            14.2.6. Others

        14.3. Market Value Forecast, by Application, 2017–2028

            14.3.1. Glucose Monitoring Products

            14.3.2. Cardiometabolic Monitoring Products

            14.3.3. Infectious Disease Testing Products

            14.3.4. Pregnancy & Fertility Testing Products

            14.3.5. Urinalysis Testing Products

            14.3.6. Cholesterol Testing Products

            14.3.7. Hematology Testing Products

            14.3.8. Drugs-of-abuse Testing Products

            14.3.9. Others

        14.4. Market Value Forecast, by End-user, 2017–2028

            14.4.1. Hospitals

            14.4.2. Diagnostic Laboratories

            14.4.3. Clinics/Physician Offices

            14.4.4. Home Care

            14.4.5. Others

        14.5. Market Value Forecast, by Country/Sub-Region, 2017–2028

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Platform

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-Region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company, 2020

        15.3. Company Profiles

            15.3.1. F. Hoffmann-La Roche Ltd.

                15.3.1.1. Overview (HQ, Employee Strength, Business Segments)

                15.3.1.2. Financials

                15.3.1.3. Recent Developments & Strategy

                15.3.1.4. SWOT Analysis

            15.3.2. bioMérieux SA

                15.3.2.1. Overview (HQ, Employee Strength, Business Segments)

                15.3.2.2. Financials

                15.3.2.3. Recent Developments & Strategy

                15.3.2.4. SWOT Analysis

            15.3.3. Johnson & Johnson Services, Inc.

                15.3.3.1. Overview (HQ, Employee Strength, Business Segments)

                15.3.3.2. Financials

                15.3.3.3. Recent Developments & Strategy

                15.3.3.4. SWOT Analysis

            15.3.4. Cardinal Health, Inc.

                15.3.4.1. Overview (HQ, Employee Strength, Business Segments)

                15.3.4.2. Financials

                15.3.4.3. Recent Developments & Strategy

                15.3.4.4. SWOT Analysis

            15.3.5. Siemens AG

                15.3.5.1. Overview (HQ, Employee Strength, Business Segments)

                15.3.5.2. Financials

                15.3.5.3. Recent Developments & Strategy

                15.3.5.4. SWOT Analysis

            15.3.6. Bio Rad Laboratories, Inc.

                15.3.6.1. Overview (HQ, Employee Strength, Business Segments)

                15.3.6.2. Financials

                15.3.6.3. Recent Developments & Strategy

                15.3.6.4. SWOT Analysis

            15.3.7. BD

                15.3.7.1. Overview (HQ, Employee Strength, Business Segments)

                15.3.7.2. Financials

                15.3.7.3. Recent Developments & Strategy

                15.3.7.4. SWOT Analysis

            15.3.8. Abbott

                15.3.8.1. Overview (HQ, Employee Strength, Business Segments)

                15.3.8.2. Financials

                15.3.8.3. Recent Developments & Strategy

                15.3.8.4. SWOT Analysis

            15.3.9. Danaher Corporation

                15.3.9.1. Overview (HQ, Employee Strength, Business Segments)

                15.3.9.2. Financials

                15.3.9.3. Recent Developments & Strategy

                15.3.9.4. SWOT Analysis

            15.3.10. Thermo Fisher Scientific, Inc.

                15.3.10.1. Overview (HQ, Employee Strength, Business Segments)

                15.3.10.2. Financials

                15.3.10.3. Recent Developments & Strategy

                15.3.10.4. SWOT Analysis

    List of Tables

    Table 01: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017‒2028

    Table 02: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2028

    Table 03: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2028

    Table 04: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2028

    Table 05: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2028

    Table 06: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017‒2028

    Table 07: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2028

    Table 08: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2028

    Table 09: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2028

    Table 10: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017‒2028

    Table 11: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2028

    Table 12: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2028

    Table 13: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

    Table 14: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017‒2028

    Table 15: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2028

    Table 16: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2028

    Table 17: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2028

    Table 18: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017‒2028

    Table 19: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2028

    Table 20: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2028

    Table 21: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2028

    Table 22: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Platform, 2017‒2028

    Table 23: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017–2028

    Table 24: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2028

    List of Figures

    Figure 01: Global Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017–2028

    Figure 02: Point-of-Care Diagnostics Market Value Share, by Platform, 2020

    Figure 03: Point-of-Care Diagnostics Market Value Share, by Application, 2020

    Figure 04: Point-of-Care Diagnostics Market Value Share, by End-user, 2020

    Figure 05: Global Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028

    Figure 06: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021–2028

    Figure 07: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Lateral Flow Assays, 2017‒2028

    Figure 08: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Dipsticks, 2017‒2028

    Figure 09: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Microfluidics, 2017‒2028

    Figure 10: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Molecular Diagnostics, 2017‒2028

    Figure 11: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Immunoassays, 2017‒2028

    Figure 12: Global Point-of-Care Diagnostics Market Value (US$ Mn), by Others, 2017‒2028

    Figure 13: Global Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028

    Figure 14: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021–2028

    Figure 15: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Glucose Monitoring Products, 2017–2028

    Figure 16: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Cardiometabolic Monitoring Products, 2017–2028

    Figure 17: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Infectious Disease Testing Products, 2017–2028

    Figure 18: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Pregnancy & Fertility Testing Products, 2017–2028

    Figure 19: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Urinalysis Testing Products, 2017–2028

    Figure 20: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Cholesterol Testing Products, 2017–2028

    Figure 21: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Hematology Testing Products, 2017–2028

    Figure 22: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Drugs-of-abuse Testing Products, 2017–2028

    Figure 23: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Others, 2017–2028

    Figure 24: Global Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028

    Figure 25: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021–2028

    Figure 26: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Hospitals, 2017–2028

    Figure 27: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Diagnostic Laboratories, 2017–2028

    Figure 28: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Clinics/Physician Offices, 2017–2028

    Figure 29: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Home Care, 2017–2028

    Figure 30: Global Point-of-Care Diagnostics Market Revenue (US$ Mn), by Others, 2017–2028

    Figure 31: Global Point-of-Care Diagnostics Market Value Share Analysis, by Region, 2020 and 2028

    Figure 32: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Region, 2021–2028

    Figure 33: North America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017–2028

    Figure 34: North America Point-of-Care Diagnostics Market Value Share Analysis, by Country, 2020 and 2028

    Figure 35: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Country, 2021–2028 

    Figure 36: North America Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028

    Figure 37: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021–2028

    Figure 38: North America Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028

    Figure 39: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021–2028

    Figure 40: North America Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028

    Figure 41: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021–2028

    Figure 42: Europe Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017–2028

    Figure 43: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028

    Figure 44: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

    Figure 45: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028

    Figure 46: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021–2028

    Figure 47: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028

    Figure 48: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021–2028

    Figure 49: Europe Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028

    Figure 50: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021–2028

    Figure 51: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017–2028

    Figure 52: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

    Figure 53: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

    Figure 54: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028

    Figure 55: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021–2028

    Figure 56: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028

    Figure 57: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021–2028

    Figure 58: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028

    Figure 59: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021–2028

    Figure 60: Latin America Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017–2028

    Figure 61: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028

    Figure 62: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-Region, 2021-2028

    Figure 63: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028

    Figure 64: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021–2028

    Figure 65: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028

    Figure 66: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021–2028

    Figure 67: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028

    Figure 68: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021–2028

    Figure 69: Middle East & Africa Point-of-Care Diagnostics Market Value (US$ Mn) Forecast, 2017–2028

    Figure 70: Middle East & Africa Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-Region, 2020 and 2028

    Figure 71: Middle East & Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-Region, 2021-2028

    Figure 72: Middle East & Africa Point-of-Care Diagnostics Market Value Share Analysis, by Platform, 2020 and 2028

    Figure 73: Middle East & Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Platform, 2021–2028

    Figure 74: Middle East & Africa Point-of-Care Diagnostics Market Value Share Analysis, by Application, 2020 and 2028

    Figure 75: Middle East & Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Application, 2021–2028

    Figure 76: Middle East & Africa Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2020 and 2028

    Figure 77: Middle East & Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2021–2028

Copyright © Transparency Market Research, Inc. All Rights reserved